RemeGen Co., Ltd. (HKG:9995)
Hong Kong · Delayed Price · Currency is HKD 89.35
-0.60 (-0.67%)
May 15, 2026, 4:09 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 65.18 billion as of May 15, 2026. Its market cap has increased by 167.56% in one year.
Market Cap
65.18B
Enterprise Value
64.44B
Revenue
3.84B
Ranking
n/a
PE Ratio
33.67
Stock Price
89.35
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 65.18B, an increase of 95.21%. That is a compound annual growth rate of 12.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 65.18B | 44.20% |
| Dec 31, 2025 | 45.20B | 222.75% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innovent Biologics | 142.29B |
| WuXi Biologics | 139.36B |
| Akeso | 110.72B |
| Sichuan Kelun-Biotech Biopharmaceutical | 101.81B |
| Sino Biopharmaceutical | 96.18B |
| 3SBio | 49.99B |
| Biocytogen Pharmaceuticals (Beijing) | 42.87B |
| Shanghai Junshi Biosciences | 40.13B |